Referencias

The OncoLife editorial team utilizes many references from medical literature to create the content within the care plan. The following is a list of references used to create the program.

American Cancer Society. Cancer Treatment and Survivorship Facts & Figures 2014-2015. Atlanta: American Cancer Society; 2014.

Centers for Disease Control & Lance Armstrong Foundation (2004). A National Action Plan for Cancer Survivorship: Advancing Public Health Strategies, https://www.cdc.gov/cancer/survivorship/pdf/plan.pdf,

Centers for Disease Control and Prevention (CDC). (2004). Cancer survivorship--United States, 1971-2001. MMWR. Morbidity and Mortality Weekly Report, 53(24), 526.

Aapro, M., Bernard-Marty, C., Brain, E.G., Batist. G., Erdkamp, F., Krzemieniecki, K., Leonard, R., Lluch, A., Monfardini, S., Ryberg, M., Soubeyran, P., Wedding, U. (2011). Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Annals of Oncology, 22(2), 257-267.

Abou-Mourad, Y. R., Lau, B. C., Barnett, M. J., Forrest, D. L., Hogge, D. E., Nantel, S. H., ... & Sutherland, H. J. (2010). Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens. Bone Marrow Transplantation, 45(2), 295-302.

Aleman, B. M., van den Belt-Dusebout, A. W., Klokman, W. J., van’t Veer, M. B., Bartelink, H., & van Leeuwen, F. E. (2003). Long-term cause-specific mortality of patients treated for Hodgkin’s disease. Journal of Clinical Oncology, 21(18), 3431-3439.

Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192-201.

Alfano, C. M., & Rowland, J. H. (2006). Recovery issues in cancer survivorship: a new challenge for supportive care. The Cancer Journal, 12(5), 432-443.

Baker, F., Denniston, M., Smith, T., & West, M. M. (2005). Adult cancer survivors: how are they faring? Cancer, 104(S11), 2565-2576.

Baker, K. S., Ness, K. K., Steinberger, J., Carter, A., Francisco, L., Burns, L. J., ... & Bhatia, S. (2007). Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood, 109(4), 1765-1772.

Barry, E., Alvarez, J. A., Scully, R. E., Miller, T. L., & Lipshultz, S. E. (2007). Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opinion on Pharmacotherapy, 8(8), 1039-1058.

Baum, M., Buzdar, A., Cuzick, J., Forbes, J., Houghton, J., Howell, A., & Sahmoud, T. (2003). Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer, 98(9), 1802-1810.

Beasley, G. M., Caudle, A., Petersen, R. P., McMahon, N. S., Padussis, J., Mosca, P. J., ... & Andtbacka, R. H. (2009). A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. Journal of the American College of Surgeons, 208(5), 706-715.

Bhatia, S., Yasui, Y., Robison, L. L., Birch, J. M., Bogue, M. K., Diller, L., ... & Reaman, G. (2003). High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. Journal of Clinical Oncology, 21(23), 4386-4394.

Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A., ... & Kurth, A. E. (2016). Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA, 315(23), 2564-2575.

Bokemeyer, C., Berger, C. C., Kuczyk, M. A., & Schmoll, H. J. (1996). Evaluation of long-term toxicity after chemotherapy for testicular cancer. Journal of Clinical Oncology, 14(11), 2923-2932.

Bower, J. E. (2005). Prevalence and causes of fatigue after cancer treatment: the next generation of research. Journal of Clinical Oncology, 23(33), 8280-8282.

Braun, I. M., Greenberg, D. B., & Pirl, W. F. (2008). Evidenced-based report on the occurrence of fatigue in long-term cancer survivors. Journal of the National Comprehensive Cancer Network, 6(4), 347-354.

Brigden, M. L. (2001). Detection, education and management of the asplenic or hyposplenic patient. American Family Physician, 63(3), 499-506.

Buchegger, F., Antonescu, C., Delaloye, A. B., Helg, C., Kovacsovics, T., Kosinski, M., ... & Ketterer, N. (2006). Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma. British Journal of Cancer, 94(12), 1770-1776.

Burke, W. M., Orr, J., Leitao, M., Salom, E., Gehrig, P., Olawaiye, A. B., ... & SGO Clinical Practice Endometrial Cancer Working Group. (2014). Endometrial cancer: a review and current management strategies: part II. Gynecologic Oncology, 134(2), 393-402.

Buzdar, A. U. (2004). Data from the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trial. Clinical Cancer Research, 10(1), 355s-361s.

Camp-Sorrell, D. (2006). Cardiorespiratory Effects in Cancer Survivors: Cardiac and pulmonary toxicities may occur as late or long-term sequelae of cancer treatment. Cancer Nursing, 29(2), 55-59.

Cannon, G. W. (1997). Methotrexate pulmonary toxicity. Rheumatic Disease Clinics of North America, 23(4), 917-937.

Cardous‐Ubbink, M. C., Heinen, R. C., Langeveld, N. E., Bakker, P. J. M., Voute, P. A., Caron, H. N., & Van Leeuwen, F. E. (2004). Long‐term cause‐specific mortality among five‐year survivors of childhood cancer. Pediatric blood & cancer, 42(7), 563-573.

Carver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., ... & Vaughn, D. J. (2007). American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. Journal of Clinical Oncology, 25(25), 3991-4008.

(2007). American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. Journal of Clinical Oncology, 25(25), 3991-4008.

Chaudhary, U. B., & Haldas, J. R. (2003). Long-term complications of chemotherapy for germ cell tumours. Drugs, 63(15), 1565-1577.

Cohen, E. E. W., LaMonte, S. J., Erb, N. L., Beckman, K. L., Sadeghi, N., Hutcheson, K. A., Stubblefield, M. D., Abbott, D. M., Fisher, P. S., Stein, K. D., Lyman, G. H. and Pratt-Chapman, M. L. (2016), American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA: A Cancer Journal for Clinicians, 66: 203–239. doi:10.3322/caac.21343

Coletta, E. M. (2000). Care of the elderly patient with lower extremity amputation. The Journal of the American Board of Family Practice, 13(1), 23-34.

Demark-Wahnefried, W., Pinto, B. M., & Gritz, E. R. (2006). Promoting health and physical function among cancer survivors: potential for prevention and questions that remain. Journal of Clinical Oncology, 24(32), 5125-5131.

Deniz, K., O'Mahony, S., Ross, G., & Purushotham, A. (2003). Breast cancer in women after treatment for Hodgkin's disease. The Lancet Oncology, 4(4), 207-214.

Di Sabatino, A., Carsetti, R., & Corazza, G. R. (2011). Post-splenectomy and hyposplenic states. The Lancet, 378(9785), 86-97.

Doyle, J. J., Neugut, A. I., Jacobson, J. S., Grann, V. R., & Hershman, D. L. (2005). Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. Journal of Clinical Oncology, 23(34), 8597-8605.

Earle, C. C. (2006). Failing to plan is planning to fail: improving the quality of care with survivorship care plans. Journal of Clinical Oncology, 24(32), 5112-5116.

Earle, C. C., & Neville, B. A. (2004). Under use of necessary care among cancer survivors. Cancer, 101(8), 1712-1719.

Elisaf, M. S., Bairaktari, E. T., Nicolaides, C., Kakaidi, B., Tzallas, C. S., Katsaraki, A., & Pavlidis, N. A. (2001). Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. European Journal of Cancer, 37(12), 1510-1513.

Feuerstein, M. (2005). Cancer survivorship and work. Journal of occupational rehabilitation, 15(1), 1-2.

Fosså, S. D. (2003). Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer. Acta oncologica (Stockholm, Sweden), 43(2), 134-141.

Friedman, D. L., Rovo, A., Leisenring, W., Locasciulli, A., Flowers, M. E., Tichelli, A., ... & Socie, G. (2008). Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood, 111(2), 939-944.

Friedman, D. L., & Constine, L. S. (2006). Late effects of treatment for Hodgkin lymphoma. Journal of the National Comprehensive Cancer Network, 4(3), 249-257.

Ganz, P. A. (2006). Monitoring the physical health of cancer survivors: a survivorship-focused medical history. Journal of Clinical Oncology, 24(32), 5105-5111.

Ganz, P.A., and Erin E. Hahn. "Implementing a survivorship care plan for patients with breast cancer." Journal of Clinical Oncology 26.5 (2008): 759-767.

Ganz, P. A., Hussey, M. A., Moinpour, C. M., Unger, J. M., Hutchins, L. F., Dakhil, S. R., ... & Albain, K. S. (2008). Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. Journal of Clinical Oncology, 26(8), 1223-1230.

Ganz, P. A., Moinpour, C. M., Pauler, D. K., Kornblith, A. B., Gaynor, E. R., Balcerzak, S. P., ... & Fisher, R. I. (2003). Health status and quality of life in patients with early-stage Hodgkin’s disease treated on Southwest Oncology Group Study 9133. Journal of Clinical Oncology, 21(18), 3512-3519.

Garcia‐Rodriguez, M. J., Canales, M. A., Hernandez‐Maraver, D., & Hernandez‐Navarro, F. (2008). Late reactivation of resolved hepatitis B virus infection: An increasing complication post rituximab‐based regimens treatment?. American Journal of Hematology, 83(8), 673-675.

Gerharz, E. W., Turner, W. H., Kälble, T., & Woodhouse, C. R. J. (2003). Metabolic and functional consequences of urinary reconstruction with bowel. BJU International, 91(2), 143-149.

Gilbert, D. C., Van As, N. J., & Huddart, R. A. (2009). Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors. Expert review of anticancer therapy, 9(2), 223-233.

Gilbert D et al. (2009). Reducing treatment toxicities in the management of good prognosis testicular cancer. Expert Review of Cancer Therapy 9(2): 223-233.

(2009). Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors. Expert Reviews in Anticancer Therapy 9(2): 223-228.

Gospodarowicz, M. (2008). Testicular cancer patients: considerations in long-term follow-up. Hematology/Oncology Clinics of North America, 22(2), 245-255.

Greving, D. M., & Santacroce, S. J. (2005). Cardiovascular late effects. Journal of Pediatric Oncology Nursing, 22(1), 38-47.

Grunfeld, E. (2005). Cancer survivorship: a challenge for primary care physicians.

(2006). Looking beyond survival: how are we looking at survivorship? Journal of Clinical Oncology, 24(32), 5166-5169.

Guidry, J. J., Torrence, W., & Herbelin, S. (2005). Closing the divide: diverse populations and cancer survivorship. Cancer, 104(S11), 2577-2583.

Haddy, T. B., Adde, M. A., McCalla, J., Domanski, M. J., Datiles, M., Meehan, S. C., ... & Magrath, I. T. (1998). Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas. Journal of Clinical Oncology, 16(6), 2070-2079.

Hakenberg, O. W., Compérat, E. M., Minhas, S., Necchi, A., Protzel, C., & Watkin, N. (2015). EAU guidelines on penile cancer: 2014 update. European Urology, 67(1), 142-150.

Hanson, K., & Kriescher, M. (2006). Cancer survivorship: State policy issues. National Conference of State Legislatures.

Hanson, K. (2006). State cancer survivorship policies. NCSL Legisbrief, 14(47), 1.

Hawkins, R.(2006). "Osteoporosis. Cancer survivors are at increased risk for osteoporosis, but how their management differs from that of the general population remains unclear. " American Journal of Nursing 106(3 Suppl): 78-82.

Haylock, P. J., Mitchell, S. A., Cox, T., Temple, S. V., & Curtiss, C. P. (2007).The cancer survivor's prescription for living. AJN The American Journal of Nursing, 107(4), 58-70.

Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., Mariscal, C. S., ... & Hancock, S. L. (2006). Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. Journal of Clinical Oncology, 25(1), 43-49.

Henderson, T. O., Whitton, J., Stovall, M., Mertens, A. C., Mitby, P., Friedman, D., ... & Robison, L. (2007). Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute, 99(4), 300-308.

Hequet, O., Le, Q. H., Moullet, I., Pauli, E., Salles, G., Espinouse, D., ... & Bouafia, F. (2004). Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. Journal of Clinical Oncology, 22(10), 1864-1871.

Herman, D. R., Ganz, P. A., Petersen, L., & Greendale, G. A. (2005). Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS). Breast Cancer Research and Treatment, 93(1), 13-23.

Hodgson, D. C. (2008). Hodgkin lymphoma: the follow-up of long-term survivors. Hematology/Oncology Clinics of North America, 22(2), 233-244.

Hodgson, D. C., Grunfeld, E., Gunraj, N., & Del Giudice, L. (2010). A population‐based study of follow‐up care for Hodgkin lymphoma survivors. Cancer, 116(14), 3417-3425.

Hoffman, B., & Stovall, E. (2006). Survivorship perspectives and advocacy. Journal of Clinical Oncology, 24(32), 5154-5159.

Houldin, A., Curtiss, C. P., & Haylock, P. J. (2006). Executive summary: The state of the science on nursing approaches to managing late and long-term sequelae of cancer and cancer treatment. AJN The American Journal of Nursing, 106(3), 54-59.

(2006). The state of the science on nursing approaches to managing late and long-term sequelae of cancer and cancer treatment. Clinical Journal of Oncology Nursing, 10(3), 327.

Huddart, R. A., Norman, A., Moynihan, C., Horwich, A., Parker, C., Nicholls, E., & Dearnaley, D. P. (2005). Fertility, gonadal and sexual function in survivors of testicular cancer. British Journal of Cancer, 93(2), 200-207.

Hudson, M. M. (2005). A model for care across the cancer continuum. Cancer, 104(S11), 2638-2642.

National Research Council. (2005). From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press.

Jacene, H. A., Filice, R., Kasecamp, W., & Wahl, R. L. (2007). Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice. Journal of Nuclear Medicine, 48(11), 1767-1776.

Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104(10), 2222-2233.

Jensen, B. V. (2006, June). Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer. In Seminars in oncology (Vol. 33, pp. 15-21). WB Saunders.

Johnson, S. A. (2006, June). Anthracycline-induced cardiotoxicity in adult hematologic malignancies. In Seminars in oncology (Vol. 33, pp. 22-27). WB Saunders.

Jones, K. W. (2000). A family physician's guide to monitoring methotrexate. American Family Physician, 62(7).

Josting, A., Wiedenmann, S., Franklin, J., May, M., Sieber, M., Wolf, J., ... & Diehl, V. (2003). Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin’s disease: a report from the German Hodgkin’s Lymphoma Study Group. Journal of Clinical Oncology, 21(18), 3440-3446.

Kaufman, M. R., & Chang, S. S. (2007). Short-and long-term complications of therapy for testicular cancer. Urologic Clinics of North America, 34(2), 259-268.

Keefe, D. L. (2001, August). Anthracycline-induced cardiomyopathy. In Seminars in Oncology (Vol. 28, pp. 2-7). WB Saunders.

Khan, N. F., Carpenter, L., Watson, E., & Rose, P. W. (2010). Cancer screening and preventative care among long-term cancer survivors in the United Kingdom. British Journal of Cancer, 102(7), 1085-1090.

Koya, M. P., Simon, M. A., & Soloway, M. S. (2006). Complications of intravesical therapy for urothelial cancer of the bladder. The Journal of Urology, 175(6), 2004-2010.

Lackner, J. E., Märk, I., Schatzl, G., Marberger, M., & Kratzik, C. (2007). Hypogonadism and androgen deficiency symptoms in testicular cancer survivors. Urology, 69(4), 754-758.

Lamm, D. L., Van der Meijden, P. M., Morales, A. L. V. A., Brosman, S. A., Catalona, W. J., Herr, H. W., ... & Debruyne, F. M. (1992). Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. Journal of Urology 147(3), 596-600.

Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., ... & Oktay, K. (2006). American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of Clinical Oncology, 24(18), 2917-2931.

Leigh, S. (2006). Cancer Survivorship: A First-Person Perspective: A nurse recounts her journey as patient, survivor, and advocate. AJN The American Journal of Nursing, 106, 12-14.

Leitao, M. M., & Chi, D. S. (2005). Fertility-sparing options for patients with gynecologic malignancies. The Oncologist, 10(8), 613-622.

Lockwood-Rayermann, S. (2006). Survivorship issues in ovarian cancer: a review. Oncology Nursing Forum, 33(3), 553-62.

Lowe, T., Bhatia, S., & Somlo, G. (2007). Second malignancies after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 13(10), 1121-1134.

Lubow, M., Grzybowski, D. M., & Awad, H. (2008). Denilieukin diftitox vision loss is not posterior ischemic optic neuropathy. Leukemia & lymphoma, 49(2), 370-371.

Ludwig, H., Miguel, J. S., Dimopoulos, M. A., Palumbo, A., Sanz, R. G., Powles, R., ... & Romeril, K. (2014). International Myeloma Working Group recommendations for global myeloma care. Leukemia, 28(5), 981-992.

Majhail, N. S., Ness, K. K., Burns, L. J., Sun, C. L., Carter, A., Francisco, L., ... & Baker, K. S. (2007). Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biology of Blood and Marrow Transplantation, 13(10), 1153-1159.

Malcolm, J. B., Bagrodia, A., Derweesh, I. H., Mehrazin, R., DiBlasio, C. J., Wake, R. W., ... & Patterson, A. L. (2009). Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy. BJU international, 104(4), 476-481.

Manikantan, K., Khode, S., Dwivedi, R. C., Palav, R., Nutting, C. M., Rhys-Evans, P., ... & Kazi, R. (2009). Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer treatment reviews, 35(8), 744-753.

McCaffrey J. A., & Scher, H. I. (1998). Interstitial pneumonitis following bicalutamide treatment for prostate cancer. The Journal of Urology, 160(1), 131.

Meadows, A. T. (2003). Pediatric cancer survivors: past history and future challenges. Current Problems in Cancer, 27(3), 112-126.

(2006). Pediatric cancer survivorship: research and clinical care. Journal of Clinical Oncology, 24(32), 5160-5165.

Meinardi, M. T., Gietema, J. A., Van Der Graaf, W. T. A., Van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., ... & Koops, H. S. (2000). Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. Journal of Clinical Oncology, 18(8), 1725-1732.

Meinardi, M. T., Gietema, J. A., Van Veldhuisen, D. J., van der Graaf, W. T. A., de Vries, E. G. E., & Sleijfer, D. T. (2000). Long-term chemotherapy-related cardiovascular morbidity. Cancer Treatment Reviews, 26(6), 429-447.

Trotter, S. C., Sroa, N., Winkelmann, R. R., Olencki, T., & Bechtel, M. (2013). A global review of melanoma follow-up guidelines. Journal of Clinical & Aesthetic Dermatology, 6(9).

Michaud, L. B., & Goodin, S. (2006). Cancer-treatment-induced bone loss, part 1. American journal of Health-System Pharmacy, 63(5).

(2006). Cancer-treatment-induced bone loss, part 2. American Journal of Health System Pharmacy 63(6): 534-46.

Moleski, M. (2000). Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology, 15(7), 603-630.

Mrozek, E., & Shapiro, C. L. (2005). Survivorship and complications of treatment in breast cancer. Clinical advances in Hematology & Oncology: H&O, 3(3), 211-22.

Mukamel, E. L. I. A. H. U., Konichezky, M., Engelstein, D., Cytron, S., Abramovici, A., & Servadio, C. (1990). Clinical and pathological findings in prostates following intravesical bacillus Calmette-Guerin instillations. The Journal of urology, 144(6), 1399-1400.

National Cancer Institute. (2013). Genetic Testing for Hereditary Cancer Syndromes. https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet

Nayfield, S. G., & Gorin, M. B. (1996). Tamoxifen-associated eye disease. A review. Journal of Clinical Oncology, 14(3), 1018-1026.

Nelson, M. B., & Meeske, K. (2005). Recognizing health risks in childhood cancer survivors. Journal of the American Academy of Nurse Practitioners, 17(3), 96-103.

Nieman, C. L., Kazer, R., Brannigan, R. E., Zoloth, L. S., Chase-Lansdale, P. L., Kinahan, K., ... & Woodruff, T. K. (2006). Cancer survivors and infertility: a review of a new problem and novel answers. Journal of Supportive Oncology 4(4), 171-178.

Noorda, E. M., van Kreij, R. H. J., Vrouenraets, B. C., Nieweg, O. E., Muller, M., Kroon, B. B. R., & Aaronson, N. K. (2007). The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion. European Journal of Surgical Oncology (EJSO), 33(6), 776-782.

O'Dell, M., & Stubblefield, M. (2009). Cancer Rehabilitation: Principles and Practice. Demos Medical Publishing.

Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., ... & Schwartz, C. L. (2006). Chronic health conditions in adult survivors of childhood cancer. New England Journal of Medicine, 355(15), 1572-1582.

Oeffinger, K. C., & McCabe, M. S. (2006). Models for delivering survivorship care. Journal of Clinical Oncology, 24(32), 5117-5124.

Oktay, K. (2006). An individualized approach to fertility preservation in women with cancer. The Journal of Supportive Oncology, 4(4), 181-2, 184.

Ondrusova, M., Ondrus, D., Dusek, L., & Spanikova, B. (2008). Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer. Neoplasma, 56(6), 473-479.

Pachler, J., & Wille‐Jørgensen, P. (2005). Quality of life after rectal resection for cancer, with or without permanent colostomy. The Cochrane Library.

Park, E. M., & Rosenstein, D. L. (2014). Living with Advanced Cancer Unmet Survivorship Needs. North Carolina Medical Journal, 75(4), 279-282.

Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., ... & Banchs, J. (2014). Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 27(9), 911-939.

Polomano, R. C., & Farrar, J. T. (2006). Pain and Neuropathy in Cancer Survivors: Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. AJN The American Journal of Nursing, 106, 39-47.

Pozo, C. L., Morgan, M. A., & Gray, J. E. (2014). Survivorship issues for patients with lung cancer. Cancer Control, 21(1), 40-50.

Ram, R., Ben-Bassat, I., Shpilberg, O., Polliack, A., & Raanani, P. (2009). The late adverse events of rituximab therapy–rare but there!. Leukemia & lymphoma, 50(7), 1083-1095.

Rheingold, SR, Neugut, AI and AT Meadows (2003)."Secondary Cancers: Incidence, Risk Factors and Management" In Editors: Kufe, DW et.al. Cancer Medicine, 6 th ed., BC Decker, Ontario.

Riva, D., Giorgi, C., Nichelli, F., Bulgheroni, S., Massimino, M., Cefalo, G., ... & Pantaleoni, C. (2002). Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology, 59(1), 48-53.

Rizzo, J. D., Wingard, J. R., Tichelli, A., Lee, S. J., Van Lint, M. T., Burns, L. J., ... & Socié, G. (2006). Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 12(2), 138-151.

Robison, L. L., Green, D. M., Hudson, M., Meadows, A. T., Mertens, A. C., Packer, R. J., ... & Zeltzer, L. K. (2005). Long‐term outcomes of adult survivors of childhood cancer. Cancer, 104(S11), 2557-2564.

Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893-901.

Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., Hurria, A., Marks, L. B., LaMonte, S. J., Warner, E., Lyman, G. H. and Ganz, P. A. (2016), American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: A Cancer Journal for Clinicians, 66: 43–73. doi:10.3322/caac.21319

Salani, R., Backes, F. J., Fung, M. F. K., Holschneider, C. H., Parker, L. P., Bristow, R. E., & Goff, B. A. (2011). Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. American Journal of Obstetrics and Gynecology, 204(6), 466-478.

Sanki, A., Kroon, H. M., Kam, P. C., & Thompson, J. F. (2011). Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities. Current Problems in Surgery, 48(6), 371-430.

Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Tan, T. C., ... & Martin, R. P. (2012). Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and TrastuzumabClinical Perspective. Circulation: Cardiovascular Imaging, 5(5), 596-603.

Schaapveld, M., Aleman, B. M., van Eggermond, A. M., Janus, C. P., Krol, A. D., van der Maazen, R. W., ... & Van Imhoff, G. W. (2015). Second cancer risk up to 40 years after treatment for Hodgkin’s lymphoma. N Engl J Med, 2015(373), 2499-2511.

Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & Van Dam, F. S. (2006). Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute, 98(23), 1742-1745.

Schagen, S. B., & Van Dam, F. S. (2006). Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?. Journal of Clinical Oncology, 24(32), 5170-5171.

Maisonneuve, P., Botteri, E., & Lowenfels, A. B. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology, 135(2), 710.

Sieniawski, M., Reineke, T., Josting, A., Nogova, L., Behringer, K., Halbsguth, T., ... & Engert, A. (2008). Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. Annals of Oncology, 19(10), 1795-1801.

Simon, B., Lee, S. J., Partridge, A. H., & Runowicz, C. D. (2005). Preserving fertility after cancer. CA: A Cancer Journal for Clinicians, 55(4), 211-228.

Skolarus, T. A., Wolf, A., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., ... & Wittmann, D. A. (2014). American Cancer Society prostate cancer survivorship care guidelines. CA: A Cancer Journal for Clinicians, 64(4), 225-249.

Sleijfer, S. (2001). Bleomycin-induced pneumonitis. Chest Journal, 120(2), 617-624.

Stapleton, S., & Blaney, S. (2006). New agents for intrathecal administration. Cancer investigation, 24(5), 528-534.

Steingart, R. M., Yadav, N., Manrique, C., Carver, J. R., & Liu, J. (2013, December). Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management. In Seminars in Oncology (Vol. 40, No. 6, pp. 690-708). WB Saunders.

Steinherz, L. J., Steinherz, P. G., Tan, C. T., Heller, G., & Murphy, M. L. (1991). Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA, 266(12), 1672-1677.

Sugimura, H., & Yang, P. (2006). Long-term survivorship in lung cancer: a review. CHEST Journal, 129(4), 1088-1097.

Thomson, A. B., Critchley, H. O., Kelnar, C. J., & Wallace, W. H. B. (2002). Late reproductive sequelae following treatment of childhood cancer andoptions for fertility preservation. Best Practice & Research Clinical Endocrinology & Metabolism, 16(2), 311-334.

Tichelli, A., Passweg, J., Wójcik, D., Rovó, A., Harousseau, J. L., Masszi, T., ... & Sica, S. (2008). Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica, 93(8), 1203-1210.

Tichelli, A., Bucher, C., Rovó, A., Stussi, G., Stern, M., Paulussen, M., ... & Biedermann, B. (2007). Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood, 110(9), 3463-3471.

Van Poppel, Hendrik, et al. "Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up." Annals of Oncology 24.suppl 6 (2013): vi115-vi124.

Vardy, J., Rourke, S., & Tannock, I. F. (2007). Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. Journal of Clinical Oncology, 25(17), 2455-2463.

Vaughn, D. J., & Meadows, A. T. (2002). Cancer survivorship research: the best is yet to come. Journal of clinical oncology, 20(4), 888-890.

Vaughn, D. J., Gignac, G. A., & Meadows, A. T. (2002). Long-term medical care of testicular cancer survivors. Annals of Internal Medicine, 136(6), 463-470.

Wallace, W. H., & Anderson, R. A. (2006). Cancer survivors and infertility: where do we go from here?. The Journal of Supportive Oncology, 4(4), 183-184.

Wong, P. W., Macris, N., DiFabrizio, L., & Seriff, N. S. (1998). Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature. CHEST Journal, 113(2), 548-550.

Woodward, W. A., Strom, E. A., McNeese, M. D., Perkins, G. H., Outlaw, E. L., Hortobagyi, G. N., ... & Buchholz, T. A. (2003). Cardiovascular death and second non–breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. International Journal of Radiation Oncology* Biology* Physics, 57(2), 327-335.

Yahalom, J., & Portlock, C. S. (2011). Long-term cardiac and pulmonary complications of cancer therapy. Heart Failure Clinics, 7(3), 403-411.

Yarbro, C. H., Wujcik, D., & Gobel, B. H. (2010). Cancer nursing: Principles and practice. Boston: Jones & Bartlett Publishers.

Yabroff, K. R., Lawrence, W. F., Clauser, S., Davis, W. W., & Brown, M. L. (2004). Burden of illness in cancer survivors: findings from a population-based national sample. Journal of the National Cancer Institute, 96(17), 1322-1330.

Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010). Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. New England Journal of Medicine, 363(19), 1812-1821.

Zoltick, B. H., Jacobs, L. A., & Vaughn, D. J. (2005, September). Cardiovascular risk in testicular cancer survivors treated with chemotherapy: incidence, significance, and practice implications. In Oncology Nursing Forum (Vol. 32, No. 5).